A Weibull-PBPK model for assessing risk of arsenic-induced skin lesions in children

作者: Chung-Min Liao , Tzu-Ling Lin , Szu-Chieh Chen

DOI: 10.1016/J.SCITOTENV.2007.12.017

关键词:

摘要: Chronic arsenic exposure and skin lesions (keratosis hyperpigmentation) are inextricably linked. This paper was to quantify the children risks further recommend safe drinking water standard based on reported epidemiological data. We linked Weibull dose-response function a physiologically pharmacokinetic (PBPK) model estimate concentrations perform risk characterization. calculated odds ratios (ORs) assess relative magnitude of effect likelihood prevalence by calculating proposed Weibull-based exposed control groups associated with age group-specific PBPK predicted dimethylarsinite (MMA(III)) levels in urine. Positive relationships between exposures cumulative were found using (r2=0.91-0.96). that standards recommended be 2.2 1 microg/L for male 6 2.8 female 0-6 7-18 years groups, respectively, hyperpigmentation an excess 10(-3) 75 lifetime exposure. Risk predictions indicate estimated ORs have 95% confidence intervals 1.33-5.12, 1.74-19.15, 2.81-19.27 mean contents 283.19, 282.65, 468.81 microg/L, West Bengal, India, Bangladesh, southwestern Taiwan. Our findings also suggest increasing urinary monomethylarsonic acid (MMA) increase arsenic-induced lesions.

参考文章(60)
Michael R Easterling, Miroslav Styblo, Marina V Evans, Elaina M Kenyon, None, Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments. Journal of Pharmacokinetics and Pharmacodynamics. ,vol. 29, pp. 207- 234 ,(2002) , 10.1023/A:1020248922689
F. Le Curieux, C. Ferreccio, D. M. DeMarini, M. J. Nieuwenhuijsen, M. Rahman, J. C. Ng, W. M Anders, D. Chakraborti, K. P. Cantor, S. Olin, R. J. Bull, T. W. Gebel, A. B. DeAngelo, S. Fukushima, J. A. Roberson, H. Komulainen, D. N. Mazumder, M. Kogevinas, M. R. Karagas, C. Chen, M. Pereira, A. Meharg, Some drinking-water disinfectants and contaminants, including arsenic World Health Organization. ,vol. 84, ,(2004)
A. Gomez-Caminero, J. C. Ng, M. Moore, A. Aitio, G. Becking, M. Hughes, E. Kenyon, P. Howe, D.R. Lewis, Environmental Health Criteria 224 Arsenic and Arsenic Compounds Environmental Health Criteria. ,vol. 13, ,(2001)
Y. Bhattacharjee, A Sluggish Response to Humanity's Biggest Mass Poisoning Science. ,vol. 315, pp. 1659- 1661 ,(2007) , 10.1126/SCIENCE.315.5819.1659
Sabine Mann, Pierre-Olivier Droz, Marie Vahter, A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Toxicology and Applied Pharmacology. ,vol. 140, pp. 471- 486 ,(1996) , 10.1006/TAAP.1996.0244
Durelle T. Scott, Robert L. Runkel, Diane M. McKnight, Bettina M. Voelker, Briant A. Kimball, Elizabeth R. Carraway, Transport and cycling of iron and hydrogen peroxide in a freshwater stream: Influence of organic acids Water Resources Research. ,vol. 39, pp. 1- 14 ,(2003) , 10.1029/2002WR001768
Winston H. Yu, Charles M. Harvey, Charles F. Harvey, Arsenic in groundwater in Bangladesh: A geostatistical and epidemiological framework for evaluating health effects and potential remedies Water Resources Research. ,vol. 39, pp. 1146- ,(2003) , 10.1029/2002WR001327
Geetha Piyawadani Ranmuthugala, Kamalini Lokuge, Keith Dear, Bruce K Caldwell, Wayne Smith, Jack C Ng, Abul H Milton, Malcolm Ross Sim, S N Mitra, Access to Drinking-Water and Arsenicosis in Bangladesh Journal of Health Population and Nutrition. ,vol. 24, pp. 336- 345 ,(2006) , 10.3329/JHPN.V24I3.719
Wen-Ping Tseng, Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic Environmental Health Perspectives. ,vol. 19, pp. 109- 119 ,(1977) , 10.1289/EHP.7719109